Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Venaxis' pivotal trial of APPY1 Test passes first of two futility analyses

July 19, 2013

Macquarie University awarded grant to support development of cancer diagnostics

July 12, 2013

New York State Department of Health approves MDxHealth's prostate cancer test

July 11, 2013

[18F]-PR-04.MZ evaluated for dopamine transporter quantification in humans

July 3, 2013

Navidea Biopharmaceuticals begins phase III NAV-4694 trial

July 2, 2013

GE Healthcare presents new radiotracers for brain imaging

July 1, 2013

Myriad Genetics to conduct BRCA testing for Tesaro's niraparib studies

June 27, 2013

Luoxis Diagnostics reports results from first study of its proprietary diagnostic platform

June 26, 2013

Novel TSPO PET radioligand described with low sensitivity to human genotypes

June 26, 2013

FDA approves genotyping test for patients with hepatitis C virus

June 25, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...